Clinical Trial

HW071021 Monotherapy in Patients With Advanced Solid Tumors

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a Phase I open-label study that will evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of HW071021 monotherapy in patients with advanced solid tumors.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-11; most recent amendment 2025-12-19.
Status change: Not Yet Recruiting → Recruiting 2025-12-19
Trial Details
NCT Number NCT06882135
Lead Sponsor Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
Conditions Advanced Solid Tumors
Enrollment 76 participants
Start Date 2025-05-28
Primary Completion 2026-09-30 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-12-29